Retrospective reimbursement prices for April 2026
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined April 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices.
To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price adjustments for the following products prescribed by brand.
April 2026 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category | Month redetermined price applies |
| Generic S.O.S25 oral powder 52g sachets | S.O.S25 oral powder 52g sachets (Vitaflo International Ltd) | 30 sachet | £29.76 | £45.60 | n/a | April 2026 |
| Generic S.O.S20 oral powder 42g sachets | S.O.S20 oral powder 42g sachets (Vitaflo International Ltd) | 30 sachet | £24.07 | £36.88 | n/a | April 2026 |
| Generic S.O.S10 oral powder 21g sachets | S.O.S10 oral powder 21g sachets (Vitaflo International Ltd) | 30 sachet | £12.02 | £23.02 | n/a | April 2026 |
| Generic S.O.S15 oral powder 31g sachets | S.O.S15 oral powder 31g sachets (Vitaflo International Ltd) | 30 sachet | £17.75 | £27.20 | n/a | April 2026 |
| Rifampicin 300mg capsules | Rifadin 300mg capsules (Sanofi) | 100 capsule | £36.63 | £41.31 | n/a | April 2026 |
| Rifampicin 150mg capsules | Rifadin 150mg capsules (Sanofi) | 100 capsule | £18.32 | £20.66 | n/a | April 2026 |
Under the current price change mechanism, pharmacy owners would have to wait one month before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching up with any NHS list price increases can lead to dispensing at a loss, as pharmacies will be reimbursed based on the previous NHS list price until the price change is adjusted in line with the price change timetable. The impact is more significant for products with large list price increases or for high volume lines. To avoid pharmacy owners dispensing these products at a loss, Community Pharmacy England requested DHSC to redetermine the reimbursement prices for the products listed above.
Pricing adjustments for products granted an adjustment for are planned to be included in the April 2026 Schedule of Payments (with a payment date of 1st July 2026).
Community Pharmacy England continues to seek a review of the current price change timetable for branded products so that there is no extra months’ delay in applying any new list prices changes to reimbursement.
